PATTERN OF DEVELOPMENT OF HYPERPROLACTINEMIA AFTER INITIATION OF HALOPERIDOL THERAPY

Citation
M. Spitzer et al., PATTERN OF DEVELOPMENT OF HYPERPROLACTINEMIA AFTER INITIATION OF HALOPERIDOL THERAPY, Obstetrics and gynecology, 91(5), 1998, pp. 693-695
Citations number
8
Categorie Soggetti
Obsetric & Gynecology
Journal title
ISSN journal
00297844
Volume
91
Issue
5
Year of publication
1998
Part
1
Pages
693 - 695
Database
ISI
SICI code
0029-7844(1998)91:5<693:PODOHA>2.0.ZU;2-2
Abstract
Objective: To determine the time it takes for prolactin (PRL) levels t o increase after initiation of therapy with haloperidol (a neuroleptic medication) and the pattern and extent of the increase. Methods: Seve nteen individuals scheduled to be given treatment with neuroleptic dru gs were enrolled. Baseline blood specimens were collected for PRL and TSH levels. Follow-up samples for PRL determinations were obtained eve ry 3 days for 18 days after initiation of haloperidol therapy. Results : There were 17 subjects: 14 women and three men. Two of the subjects were found to have hyperprolactinemia due to hypothyroidism and were e xcluded from the basic study. The 15 remaining subjects all had normal baseline PRL levels and normal TSH values. The PRL levels in all 15 s howed a similar pattern: a rapid increase in PRL levels in the first 6 -9 days, followed by a plateau that remained, with minor fluctuations, throughout the study. The highest mean peak level of PRL was 37.4 ng/ mL and the maximum was 77 ng/mL. The two individuals with hypothyroidi sm had somewhat elevated baseline PRL levels; although they showed the same initial pattern of increase after haloperidol administration, th eir PRL levels reached values well above 100 ng/mL. Conclusion: There is a distinct pattern of response of PRL to haloperidol. The PRL level increases for 6-9 days, then plateaus, the peak being between 30 and 50 ng/mL, and always remains below 77 ng/mL. In our study, levels that continued to increase, or increased above 77 ng/mL, indicated the pre sence of hypothyroidism. The patterns and levels of the increase were uninfluenced by the therapeutic dose of the medication given. Given th at the patients in our study with elevated levels of TSH had such high levels of PRL, all patients should have TSH determinations at the ini tiation of therapy with neuroleptic medications such as haloperidol. ( C) 1998 by The American College of Obstetricians and Gynecologists.